Annovis Bio (NYSE: ANVS) a late-stage clinical drug platform company developing therapies for neurodegenerative diseases, announced that CEO Maria M ...

Q4 2024 Management View The CEO, Tony Cheng, highlighted record performance with adjusted operating earnings of $4.99 per share in Q4 2024. The company achieved a 15.4% adjusted operating return on ...

AbbVie (NYSE:ABBV) said it has received FDA approval for the intravenous antibiotic treatment Emblaveo, which was co-developed with Pfizer (NYSE:PFE). The FDA approved Emblaveo, a combination of ...

Best Medical Stocks To Buy Under $20 and 10 Best Stocks to Buy and Hold For 2025. In January 2025, the US government proposed ...

Jim Cramer, host of Mad Money, recently pointed out some unexpected trends in the stock market this year, spotlighting a ...

Celestica's valuation is now more aligned with its growth, leaving a limited margin of safety; a 15-20% dip would make it ...

Passive investors looking to better capitalize on the AI boom may wish to consider Vanguard’s more aggressive, tech-focused ...

The markets have succumbed to the headline pressure around inflation and tariffs, with all three of the major stock market indices trading in the red as of mid-morning. U.S. job growth slowed in ...

Wall Street's main indexes fell on Friday after the latest jobs data raised the prospects of a more cautious Federal Reserve, ...

All the big swings on Wall Street show again how little investors control. When it comes to tariffs, inflation or how much ...

Honeywell (NYSE: HON) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

Investing in a growing company in the stock market can help you achieve financial freedom. Investors who regularly buy shares of strong companies with above-average growth prospects can build ...